U.S. market Open. Closes in 2 hours 50 minutes

EYEG | EyeGate Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue12.06K2.69M1.65M407.52K669.26KN/AN/AN/AN/A
Cost of Revenue12.05KN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit13.002.69M1.65M407.52K669.26KN/AN/AN/AN/A
Operating Expenses8.22M9.80M12.50M14.97M14.02M6.68MN/AN/AN/A
Selling, General & Admin4.66M4.41M4.44M4.64M5.59M3.96M1.93M2.09M2.82M
Research & Development3.57M5.39M8.06M10.33M8.42M2.72M531.12K1.01M3.03M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-8.21M-7.11M-10.84M-14.56M-13.35M-6.68M-2.46M-3.10M-5.85M
Other Expenses / Income132.87K107.74K119.32K-651.003.41K-1.71M910.58K-584.68K43.88K
Before Tax Income-8.08M-7.00M-10.73M-14.56M-13.34M-8.39M-1.55M-3.68M-5.81M
Income Tax Expenses12.05K95.40K86.05K-1.34M3.68KN/AN/AN/AN/A
Net Income-8.09M-7.10M-10.81M-13.22M-13.34M-8.39M-1.77M-3.88M-6.03M
Interest Expenses4.19K325.001.04K1.22K275.001.93M441.72K611.39KN/A
Basic Shares Outstanding3.18M3.18M2.37M950.68K588.93K410.94K462.75K334.00K12.86K
Diluted Shares Outstanding3.18M3.18M2.37M950.68K588.93K410.94K462.75K334.00K12.86K
EBITDA-8.04M-6.79M-10.69M-14.54M-13.34M-6.68M-2.46M-3.09M-5.83M
EBITDA Margin-66,691.27%-252.68%-646.64%-3,567.79%-1,992.95%0.00%0.00%0.00%0.00%
EBIT-8.08M-7.00M-10.72M-14.56M-13.34M-6.46M-1.33M-3.27M-6.03M
EBIT Margin-66,968.23%-260.65%-648.97%-3,572.52%-1,993.17%0.00%0.00%0.00%0.00%
Financial Year End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙